ModernMedicine Resource Center More Topics

Video

Erectile Dysfunction: Causes and Diagnosis

University of Utah Health Care - William O. Brant, M.D., discusses the causes and diagnosis of erectile dysfunction (ED).

Erectile Dysfunction - Treatment & Diagnosis

FDA approves drug treatment for Peyronie’s disease
FDA approves drug treatment for Peyronie’s diseaseThe FDA has approved collagenase clostridium histolyticum (CCH [XIAFLEX]) as the first medication to treat of Peyronie's disease (PD).
Peyronie’s agent meets phase III study endpoints
Peyronie’s agent meets phase III study endpointsData from phase III studies of collagenase clostridium histolyticum (CCH [XIAFLEX]) showed that the agent met primary endpoints related to Peyronie’s disease (PD) curvature and symptoms, and that it is effective and safe in certain subgroups of men with PD, according to Auxilium Pharmaceuticals, Inc.
FDA approves label addition for PDE-5 inhibitor
FDA approves label addition for PDE-5 inhibitorThe FDA has approved a product label addition for the phosphodiesterase-type-5 inhibitor tadalafil (Cialis) that involves its use with finasteride (Proscar).
Are you seeing more younger patients presenting with erectile dysfunction?
Are you seeing more younger patients presenting with erectile dysfunction?Some urologists are seeing more younger men for erectile dysfunction than they have in the past, the reasons for which appear to be multi-factorial.
Best of AUA 2013: Sexual Function/Dysfunction
Best of AUA 2013: Sexual Function/DysfunctionRobert C. Dean, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in San Diego.
Sexual dysfunction, Peyronie’s research centers on medical therapies
Sexual dysfunction, Peyronie’s research centers on medical therapiesIn the area of sexual dysfunction, much of the clinical research continues to focus on medical therapies, and this will be evident at the upcoming AUA annual meeting in San Diego.
  • 1
  • 2